Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,800
Closed -$24.6K 13142
2025
Q1
$24.6K Sell
2,800
-4,700
-63% -$39.4K ﹤0.01% 12989
2024
Q4
$58.6K Buy
7,500
+6,700
+838% +$51K ﹤0.01% 12208
2024
Q3
$6.32K Hold
800
﹤0.01% 13426
2024
Q2
$7.14K Sell
800
-1,100
-58% -$10.5K ﹤0.01% 13276
2024
Q1
$22.1K Buy
+1,900
New +$19K ﹤0.01% 12940
2023
Q4
Sell
-1,500
Closed -$16.9K 14486
2023
Q3
$16.9K Buy
1,500
+200
+15% +$2.52K ﹤0.01% 12756
2023
Q2
$14.9K Buy
1,300
+200
+18% +$2.5K ﹤0.01% 12975
2023
Q1
$15.3K Sell
1,100
-4,300
-80% -$61.8K ﹤0.01% 13260
2022
Q4
$71.1K Buy
+5,400
New +$72K ﹤0.01% 11683

Other funds holding EHAB

Citadel Advisors's EHAB Position: Q2 2026 in Review

Citadel Advisors sold out of Enhabit (EHAB) in Q2 2026, closing a stake of 196,897 shares — an estimated $2.77M sold.

Citadel Advisors first reported a position in EHAB in Q3 2022 and held it in 14 quarters. The position peaked at $6.79M in Q3 2024. 1 fund tracked by Wall St. Rank holds EHAB as of Q2 2026.

  • Citadel Advisors reported no remaining Enhabit position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 196,897 Enhabit shares in Q2 2026, an estimated $2.77M.
  • Citadel Advisors first reported a position in Enhabit in Q3 2022 and held it in 14 quarters.
  • Citadel Advisors's Enhabit position peaked at $6.79M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Enhabit as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.